Skip to main content

Table 2 Drugs targeting HIF/HIF mediated metabolic enzymes

From: Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy

Drug

Target

Tumor

Ref

Atorvastatin

HIF-1α

Burkitt’s Lymphoma

[115]

Oxaliplatin

HIF-1α

Colorectal cancer

[116]

Tamoxifen

HIF-1α

Breast cancer

[109]

Trichostatin A

HIF-1α

Cervical cancer

[117]

Diacetoxyscirpenol

HIF-1α

Liver cancer

[118]

Metformin

HIF-1α

Breast cancer

[119]

Metformin

HIF-1α/GLUT, HK2, PKM, LDH

Cervical cancer

[120]

Ginsenoside Compound K

HIF-1α/PDK1

Lung cancer

[121]

Dovitinib

HIF-1α/GLUT

Lung cancer

[112]

Metformin

HIF-1α/PDH

Oral cancer

[110]

Cetuximab

HIF-1α/LDHA

Head and neck cancer

[111]

Troxacitabine

HIF-1α/PGK

Lung cancer

[122]